Kauppalehti

Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer

A particularly high unmet need remains for people who become resistant to endocrine therapies and CDK inhibitors. These study results support the potential for the giredestrant combination to become a ...
Kauppalehti

Intesa Sanpaolo's IMI Corporate & Investment Banking Division strengthens US role supporting transactions worth $50 billion in three years

WASHINGTON and MILAN, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Intesa Sanpaolo's IMI Corporate & Investment Banking Division (IMI CIB) has supported approximately $50 billion of US transactions over the last ...
Kauppalehti

Boehringer’s zongertinib demonstrated a 77% objective response rate in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC

Data from the Phase Ib Beamion LUNG-1 trial evaluating zongertinib in treatment-naïve patients with advanced HER2 ( ERBB2 )-mutant NSCLC were presented for the first time at ESMO 2025. Confirmed ...
Kauppalehti

Dolphin Liberty 600 by Maytronics Named to TIME’s List of the Best Inventions of 2025

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
Kauppalehti

StoneX Expands Wealth Management Offering for Latin American Clients

This acquisition bolsters StoneX’s existing wealth management business and further strengthens its connection with Latin America. Through this transaction, StoneX expands its ability to serve ...
Kauppalehti

NeuralTrust spots first signs of “self-fixing” AI in the wild

NeuralTrust , the security platform for AI Agents and LLMs, reported  evidence that a large language model (LLM) behaved as a “self-maintaining” agent, autonomously diagnosing and repairing a failed ...
Kauppalehti

Mark Fitzgerald Appointed President and Chief Executive Officer of Eavor Technologies Inc.

CALGARY, Alberta, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Eavor Technologies Inc. is pleased to announce the appointment of Mark Fitzgerald as its new President and Chief Executive Officer, effective ...
Kauppalehti

Novartis Kisqali® 5-year NATALEE data demonstrate 28% reduction in risk of recurrence in the broadest early breast cancer patient population

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
Kauppalehti

Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
Kauppalehti

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
Kauppalehti

WillScot Closes Amended and Extended Asset-Based Revolving Credit Facility

WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced that the Company has amended its asset-based lending credit ...
Kauppalehti

CrossAmerica Partners to Announce Third Quarter 2025 Earnings Results on November 5

ALLENTOWN, PA, October 17, 2025 – CrossAmerica Partners LP (NYSE: CAPL) today announced that it will release its third quarter 2025 results after the market closes on Wednesday, November 5, 2025. In ...